Association study between genetic variants in retinol metabolism pathway genes and prostate cancer risk

Dongliang Cao, Yixuan Meng, Shuwei Li, Junyi Xin, Shuai Ben, Yifei Cheng, Meilin Wang, Lixin Hua, Gong ChengCancer 2020 · DOI

TL;DR

This study investigates the link between genetic variations in retinol metabolism genes and prostate cancer (PCa) risk. Researchers found that specific genetic variants in ALDH1A1 and ALDH1A3 are associated with altered PCa risk, and ALDH1A3 expression is elevated in PCa tissues, suggesting these genes play a role in PCa development.

What Problem Does This Paper Address?

Prostate cancer (PCa) is a significant global health concern, ranking second in incidence and fifth in cancer-related deaths worldwide. While lifestyle factors and age are known risk factors, the role of genetic variations in PCa development is still being explored. Specifically, the connection between genes involved in retinol metabolism (vitamin A) and PCa risk has remained unclear. Retinol is crucial for various biological processes, including cell growth and differentiation, and its metabolic pathway involves several enzymes. Understanding how genetic variations in these enzymes influence PCa risk could lead to better risk assessment and potentially new therapeutic targets.

Methods

The researchers employed a multi-faceted approach to investigate the association between retinol metabolism genes and PCa risk.

  • SNP Genotyping and Association Analysis: They utilized data from the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial, which included a large cohort of PCa cases and controls. Single-nucleotide polymorphisms (SNPs) in 31 genes within the retinol metabolism pathway were selected. After rigorous quality control and linkage disequilibrium (LD) analysis, 167 SNPs were analyzed. Statistical methods included Chi-square tests, unconditional univariate and multivariate logistic regression to calculate odds ratios (ORs) and confidence intervals (CIs), and false discovery rate (FDR) for multiple comparison correction.
  • Gene Expression Analysis: To understand the functional implications of these genetic variants, the researchers analyzed gene expression data from the Gene Expression Omnibus (GEO) datasets and The Cancer Genome Atlas (TCGA) database. They compared mRNA levels of target genes in prostate cancer tissues versus normal tissues.
  • Expression Quantitative Trait Loci (eQTL) Analysis: To link specific SNPs to gene expression, they used data from the Genotype-Tissue Expression (GTEx) project to perform eQTL analysis, identifying if genetic variants influence the expression of nearby genes.

Datasets

  • PLCO Cancer Screening Trial: This dataset provided the primary source for genetic association studies, comprising 4,662 prostate cancer cases and 3,114 controls.
  • Gene Expression Omnibus (GEO) datasets: Used for gene expression analysis.
  • The Cancer Genome Atlas (TCGA) database: Also used for gene expression analysis.
  • Genotype-Tissue Expression (GTEx) project dataset: Utilized for expression quantitative trait loci (eQTL) analysis.

Key Insights and Ideas

  • ALDH1A1 and ALDH1A3 as PCa Risk Modifiers: The study identified specific SNPs in ALDH1A1 and ALDH1A3 that are significantly associated with altered prostate cancer risk. This suggests that variations in how these genes function can influence an individual's susceptibility to PCa.
  • ALDH1A3 Upregulation in PCa: The finding that ALDH1A3 mRNA levels are significantly higher in prostate cancer tissues compared to normal tissues is a crucial insight. This upregulation could indicate a role for ALDH1A3 in the development or progression of PCa.
  • SNP-Gene Expression Link: The identification of rs1330286 in ALDH1A1 as a significant eQTL for ALDH1A1 provides a direct link between a genetic variant and its potential functional impact on gene expression, strengthening the biological plausibility of the observed association.
  • Stratified Analysis Reveals Nuances: The stratified analyses revealed that the protective effect of the ALDH1A1 variant (GG genotype) was more pronounced in certain age groups and Gleason scores, suggesting that genetic risk factors might interact with other clinical parameters.

Key Results

  • Two SNPs were significantly associated with prostate cancer risk after FDR correction:
  • rs1330286 in ALDH1A1: Associated with a decreased risk of prostate cancer (OR = 0.88, 95% CI = 0.83-0.94, p = 2.45 × 10⁻⁴ in the additive model).
  • rs4646653 in ALDH1A3: Associated with an increased risk of prostate cancer (OR = 1.17, 95% CI = 1.07-1.27, p = 4.33 × 10⁻⁴ in the additive model).
  • The mRNA level of ALDH1A3 was significantly higher in prostate cancer tissues than in normal tissues in both TCGA and GEO datasets (p = 1.63 × 10⁻¹² and p = 4.33 × 10⁻², respectively).
  • rs1330286 was identified as a significant eQTL for ALDH1A1 in prostate tissue samples (p = 2.90 × 10⁻³).

Limitations and Future Work

  • Sample Size for Gene Expression: The authors note that the limited sample size for gene expression analysis of ALDH1A1 might explain the lack of a significant difference between tumor and normal tissues, suggesting that larger tissue sample studies are needed.
  • Other Genetic Variants: The study focused on SNPs. However, other genetic variations like insertions/deletions (InDels), copy number variations (CNVs), and rearrangements could also contribute to PCa carcinogenesis and were not investigated. Future research could explore these.
  • eQTL Data Availability: The eQTL data for rs4646653 in ALDH1A3 was not available in the GTEx dataset, limiting the ability to directly link this specific SNP to ALDH1A3 expression. Further research is needed to clarify this relationship.
  • Functional Studies: While the study provides genetic and expression data, further biological research is required to fully elucidate the precise functions of these retinol-related genes in PCa carcinogenesis and development.

Summary updated

Abstract

Our findings highlight that genetic variants in retinol metabolism pathway genes are associated with prostate cancer risk.
BibTeX
@inproceedings{cao2020association,
  author = {Dongliang Cao and Yixuan Meng and Shuwei Li and Junyi Xin and Shuai Ben and Yifei Cheng and Meilin Wang and Lixin Hua and Gong Cheng},
  title = {{Association study between genetic variants in retinol metabolism pathway genes and prostate cancer risk}},
  booktitle = {Cancer},
  year = {2020},
  doi = {10.1002/cam4.3538},
}
Figure